Radical Lung Cancer Surgery: Clinical Trials

1 recruiting. 1 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	1	Recruiting 1

Follow Radical Lung Cancer Surgery: new trials by email Literature Review of Radical Lung Cancer Surgery trials Research Report on Radical Lung Cancer Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC Oral Paclitaxel Solution, PD-1/PD-L1 inhibitor, Stereotactic Body Radiotherapy (SBRT) - NSCLC (Non-small Cell Lung Cancer)	Phase 4	Recruiting	Shanghai Pulmonary Hospital, Shanghai, China	78	2026-06-25	2026-08-10

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Pathologic Complete Response (1)

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China (1)

Countries

China (1)

Top investigators

Xiaoling Xu, MD, PhD (1)

Results publications

PMID 33096027, PMID 34086039, PMID 37478883, PMID 38512301, PMID 38610980, PMID 39305910, PMID 39614293